✦ LIBER ✦
PARP inhibition synergizes with anti-CTLA-4 immune therapy to promote rejection of peritoneal tumors in mouse models of ovarian cancer
✍ Scribed by Higuchi, T.; Flies, D.; Mantia-Smaldone, G.M.; Ronner, P.L.; Alldredge, J.; Orsulic, S.; Adams, S.F.
- Book ID
- 127194483
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 176 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.